Clinical Trial Update: Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults [Phase 1]

View source ↗

Summary

Phase I safety study of a Streptococcus pneumoniae whole-cell vaccine with alum adjuvant (SPWCV+Al) in healthy adults; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pneumococcal Disease
• Pneumococcal Infections
• Pneumococcal Pneumonia

Drugs mentioned

• Streptococcus pneumoniae whole-cell vaccine (SPWCV) with alum (Streptococcus pneumoniae whole-cell vaccine with aluminum adjuvant)

Snippet

Sponsor: PATH Vaccine Solutions | Conditions: Pneumococcal Vaccines | Phase 1 | Status: COMPLETED | Results posted: 2014-06-05